Back to Authors

Rohr, K B

A5013605797 | I1330995197

Mayo Clinic

Boehringer Ingelheim (Germany)

Citations 1

Effects of nintedanib in patients with progressive fibrosing interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in the INBUILD trial*

Pneumologie | June 8, 2022 | Volume: 76 | Issue: S 01 | Pages: S21-S21

10.1055/s-0042-1747733